ArticleJugan geon-gang gwa jilbyeong2025
[Laboratory Biosafety Guideline (2025) Revision].
Article in Jugan geon-gang gwa jilbyeong, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The Korea Disease Control and Prevention Agency sought to revise the Laboratory Biosafety Guideline, creating a fourth (2025) edition of the Laboratory Biosafety Guideline, to provide updated safe laboratory environment for researchers at domestic medical and bioscience research institutions. Methods: Domestic and international biosafety-related laws, regulations, and criteria were investigated and analyzed. Results: The fourth edition of the Laboratory Biosafety Guideline (2025) was found to provide guidance on international laboratory-biosafety criteria, such as risk-assessment procedures, accident-prevention policies, and response measures, that corresponded to the World Health Organization Laboratory Biosafety Manual, 4th edition and the Biosafety in Microbiological and Biomedical Laboratories, 6th edition of the U.S. Centers for Disease Control and Prevention. Conclusions: The revised Laboratory Biosafety Guideline (2025) are expected to provide a safe experimental environment for researchers, with guidelines for preventing both laboratory infections and infectious-material leaks in research facilities handling pathogens and exposure to pathogens in the community. The guidelines will serve as an excellent reference for researchers managing laboratory biosafety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.